American Marconi Wireless News - News from Boston, Massachusetts, the USA and the world, around the clock every day

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

– Production Also Remains Strong at the Pilar Mine

VANCOUVER, BC / ACCESS Newswire / August 13, 2026 / Redwood AI Corp. (CSE:AIRX)(OTCQB:RDWCF)(Frankfurt:Y0N)(WKN:A422EZ) ("Redwood" or the "Company") is pleased to announce, further to its news releases dated May 28, 2026, June 26, 2026 and July 6, 2026, that it has completed the acquisition (the "Acquisition") of all of the issued and outstanding shares of Quantum.IQ Technologies Inc. ("Quantum.IQ"). Quantum.IQ is a Vancouver-based quantum cybersecurity company developing software designed to help organizations assess and prepare their encryption systems for future quantum-enabled cyber threats. As a result of the Acquisition, Quantum.IQ is now a wholly owned subsidiary of Redwood.

The FBI released 64 pages and withheld 147 more, most of them protected under grand jury secrecy rules. The records were provided to The Newsground by researcher Joe Lloyd, who filed the FOIA request for FBI materials mentioning Curaleaf.MMJ International Holdings says entry into the federal controlled-substances system may expose applicants' ownership, financing, compliance histories and diversion controls to scrutiny far beyond state licensing reviews.

VANCOUVER, BC / ACCESS Newswire / August 13, 2026 / Orogen Royalties Inc. ("Orogen" or the "Company") (TSXV:OGN)(OTCQX:OGNNF) is pleased to announce the voting results for its Annual General Meeting (the "Meeting") of shareholders held August 13, 2026. A total of 18,758,519 shares were voted by proxy representing 31.60% of the issued and outstanding shares of the Company. Shareholders approved all matters presented at the meeting as follows:

Edison Innovations-Bridgelux Licensing Agreement Becomes First U.S. Deal for the Manufacturing of KSF LED Displays for the Global Market

REDMOND, WA / ACCESS Newswire / August 13, 2026 / MicroVision, Inc. (NASDAQ:MVIS) ("MicroVision" or "Company"), a leader in advanced perception solutions for industrial, security and defense, and automotive applications, today announced that it has commenced a public offering, subject to market and other conditions, to offer and sell units, consisting of (i) one share of common stock (or pre-funded warrant in lieu thereof) and (ii) one warrant to purchase one share of common stock. All of the shares of common stock, pre-funded warrants and accompanying warrants are being offered by MicroVision.

RALEIGH, NC / ACCESS Newswire / August 13, 2026 / Vogenx, Inc. (NASDAQ:VOGX) ("Vogenx"), a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis, today announced the closing of its initial public offering of 6,250,000 shares of its common stock at a public offering price of $13.00 per share. All of the shares were offered by Vogenx. The gross proceeds to Vogenx from the offering, before deducting underwriting discounts and commissions and other offering expenses, were approximately $81.3 million.

ARR reaches $11.5 million; NRR reaches 99.3%EngineRoom transaction establishes a $12 million-plus annualized revenue platform and expands CXAI from enterprise workplace AI into the mid-market

TORONTO, ON / ACCESS Newswire / August 13, 2026 / Predictiv AI Inc. (CSE:PAI) (the "Company" or "Predictiv AI") is pleased to announce that it has agreed to settle an aggregate of $298,272 of indebtedness owing to certain creditors of the Company through the issuance of an aggregate of 2,485,606 common shares in the capital of the Company (the "Common Shares") at a deemed price of $0.12 per Common Share (the "Debt Settlement"). All securities issued pursuant to the Debt Settlement will be subject to a statutory hold period expiring four months and one day from the date of issuance in accordance with applicable Canadian securities laws and the policies of the Canadian Securities Exchange (CSE).

Highlights for the quarter ended June 30, 2026:Management and advisory fee revenues were $18.8 million for each of the three months ended June 30, 2026 and 2025. The 2026 period included a 30% increase in revenues from the Company's exchange-traded funds (ETFs).Management and advisory fee revenues also benefited from an increase in the number of new accounts during the quarter and year-to-date period, which helped second quarter 2026 revenues from separately managed accounts (SMAs) grow 8.6%Operating income was $3.0 million (GAAP presentation) and $4.9 million (advisor only presentation) for the quarter ended June 30, 2026 reflecting the Company's consistent core asset management operations.Net loss attributable to Horizon Kinetics Holding Corporation of $18.4 million, or $0.99 per common share for the three months ended June 30, 2026.Assets under management (AUM) grew to $10.8 billion as of June 30, 2026, an increase of 12.1% from December 31, 2025.Board of Directors declares a $0.13 per share dividend.

Sophia the Robot presides over a mock courtroom case during the 2026 Burton Awards, exploring the intersection of artificial intelligence, law, and legal innovation.

Acquisition of Cy Biopharma Completed, Adding CY200 for Complex Regional Pain SyndromeUp to $77 million in new funding with the acquisition of Cy BiopharmaCompany to host a Corporate Update Call on Tuesday, August 18, 2026, at 11:00 a.m. ET

Clean Futures Alliance provided hygiene supplies and education to 6,300 children across three countries

WHEAT RIDGE, CO / ACCESS Newswire / August 13, 2026 / Lifeloc Technologies, Inc. (OTCID:LCTC), a global leader in the development and manufacturing of breath alcohol and drug testing devices, has announced financial results for the quarter ended June 30, 2026.

Company Reports Record Quarterly Revenues of $54.1 million, a 16.5% Year-Over-Year IncreaseBroadcast Revenues Increase to $45.8 million, a 20.5% Increase Year-Over-YearCompany Reports Net Income of $2.9 million and Adjusted EBITDA of $5.7 million, Its First Profitable Quarter as a Public Company

~ Second Quarter 2026 Revenue of $1.3 Million, a 127% Increase Compared to Prior Year ~~ Second Quarter Gross Profit of $0.8 Million, a 232% Increase Compared to Prior Year; Gross Margin of 64% ~~ Received FDA 510(k) Clearance for Updated Catamaran® SI Joint Fusion System ~~ Physician and Distributor Training Events Increased 98% in 1H 2026 Compared to 2H 2025, Supporting Record Monthly Case Volume in July 2026 ~~ Closed $4.2 Million Public Offering Subsequent to Quarter End ~

Veteran patent dealmaker with more than $11 billion in completed intellectual property transactions to lead licensing and monetization of the Company's patented Data Science and Acoustic Science portfolios

Consolidated Revenue and Gross Profit increased by 23% and 36%, respectively.

Systems Integration Revenue Increased 46% Year-Over-Year, Representing 39% of Total Revenue~$17 Million Investment Expected to Drive Increased Systems Integration Revenue from Next Generation AI Data Center Technology

WOBURN, MA / ACCESS Newswire / August 13, 2026 / Bridgeline Digital, Inc. (NASDAQ:BLIN) a leader in AI-powered marketing technology, today announced financial results for its fiscal 2026 third quarter, which ended June 30, 2026.

SAN DIEGO, CA / ACCESS Newswire / August 13, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended June 30, 2026.

Second quarter 2026 revenue increased 88.4% year-over-year to a record $59.1 millionRecord number of units transacted, 138% year-over-year increase

SEATTLE, WA / ACCESS Newswire / August 13, 2026 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics, today closed its previously announced warrant inducement transaction with certain holders of its existing common warrants (the "Existing Warrants"), pursuant to which such holders have exercised in full for cash their Existing Warrants to purchase up to an aggregate of 254,922 shares of common stock of the Company ("common stock") at a reduced exercise price of $4.03 per share. In consideration for such cash exercises, the Company has issued new unregistered common stock purchase warrants (the "Inducement Warrants") to purchase up to an aggregate of 1,274,610 shares of common stock at an exercise price of $4.03 per share. The Inducement Warrants will be exercisable on or after the date on which the Company obtains the required stockholder approval and will expire on the five-year anniversary of the date of such stockholder approval. The shares of common stock issuable upon exercise of the Existing Warrants are registered pursuant to effective registration statements on Form S-1 (File No. 333-288061), Form S-1MEF (File No. 333-288134), Form S-3 (File No. 333-284969) and Form S-3 (File No. 333-283983).

Delivers Double-Digit Revenue Growth, Gross Margin Above 50%, and Another Record Cash BalanceThis press release replaces the previous press release.

Former MedCerts COO and CPO to Lead Healthcare Growth, Workforce Partnerships and Outcomes Strategy

LOAN GROWTH 13.5%CAPITAL INCREASE 18.3%

A leading national precious metals dealer and the nation's top sound money advocacy group honor Maryland and Alaska lawmakers for advancing sound money policies

QUEBEC, QC / ACCESS Newswire / August 13, 2026 / NuRAN Wireless Inc. ("NuRAN" or the "Company") (CSE:NUR)(OTC Pink:NRRWF)(FSE:1RN), a pioneering rural connectivity company and one of Africa's fastest-growing Network-as-a-Service ("NaaS") operators, is pleased to announce that it has received an approval letter from The Nasdaq Stock Market LLC ("Nasdaq") confirming that Nasdaq has approved the Company's application to list its common shares on The Nasdaq Capital Market. Nasdaq has reserved the trading symbol "NUR" for the Company's common shares, and the anticipated date of initial trading on Nasdaq is Monday, August 17, 2026. All amounts in this news release are in Canadian dollars unless otherwise indicated.

JASPER, IN / ACCESS Newswire / August 13, 2026 / SVB&T Corporation (OTCQX:SVBT), parent company of Springs Valley Bank & Trust Company, today announced 2026 second quarter unaudited earnings of $3.04 million or $2.75 basic earnings per share (EPS), a 41.75% increase over the same prior year period earnings on a per share basis. This 2026 second quarter performance translates to a return on average assets (ROAA) of 1.84%, compared to the same prior year period ROAA of 1.34%.

ELEKTROS Inc. - Publicly Traded (Ticker Symbol: ELEK)

Dr. Louis DeJoseph reviews who may benefit from a neck lift and why surgeon credentials, aesthetic style, and realistic expectations matter when considering treatment.